OmniComm Systems (OMCM) Stock Price, News & Analysis

Company Overview

OmniComm Systems, Inc., a healthcare technology company, provides Web-based electronic data capture (EDC), and eClinical software and services for pharmaceutical and biotechnology companies, clinical research organizations (CROs), and other clinical trial sponsors worldwide. It offers TrialMaster, which allows organizations conducting clinical trials to collect and manage the data over the Internet; TrialOne Phase I Clinic Automation, a software application suite that provides clinical trial site sponsors, study investigators, and study monitors with various tools to conduct the Phase I clinic operation; and IRTMaster, which offers interactive response technology in support of the randomization process in clinical trials. The company also provides eClinical Suite that comprises a set of tools for collecting and managing clinical data, including EDC for real-time entry and double data entry (DDE) for entry from paper originals; and Promasys, a clinical trial data management system for DDE and EDC, which is primarily used at research institutions for investigator-initiated trials. In addition, it offers Acuity, a clinical data aggregation and analytics platform that provides actionable insights into quality, risk, and performance of various aspects of clinical trials in real time. Further, the company provides consulting and professional services, such as project management, clinical services, training, custom configuration, system integration, standard operating procedures and implementation assistance, installation, and validation services, as well as application hosting and related support services. It sells its products through a direct sales force and relationships with CRO partners, as well as through co-marketing agreements with vendor and channel partners. OmniComm Systems, Inc. was founded in 1996 and is headquartered in Fort Lauderdale, Florida.

Key Stats

• Today's Range: $0.41 to $0.41
• 50-Day Range: $0.41 to $0.41
• 52-Week Range: $0.01 to $0.44
• Volume: N/A
• Average Volume: 140,659 shs
• Market Capitalization: $66.04 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OMCM Stock Analysis - Frequently Asked Questions

How have OMCM shares performed this year?

OmniComm Systems' stock was trading at $0.41 at the beginning of the year. Since then, OMCM shares have increased by 0.0% and is now trading at $0.41.
View the best growth stocks for 2025 here.

How were OmniComm Systems' earnings last quarter?

OmniComm Systems, Inc. (OTCMKTS:OMCM) posted its quarterly earnings data on Tuesday, April, 3rd. The company reported $0.01 earnings per share (EPS) for the quarter. The company earned $6.80 million during the quarter. OmniComm Systems had a negative trailing twelve-month return on equity of 13.18% and a negative net margin of 2.67%.

How do I buy shares of OmniComm Systems?

Shares of OMCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of OmniComm Systems own?

Based on aggregate information from My MarketBeat watchlists, some other companies that OmniComm Systems investors own include Broadridge Financial Solutions (BR), Cenveo (CVO), ENGlobal (ENG), InterCloud Systems (ICLD), IntelGenx Technologies (IGXT), Nuance Communications (NUAN) and On Track Innovations (OTIV).

Company Calendar

• Last Earnings: 4/03/2018
• Today: 4/02/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Business Services
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:OMCM
• CIK: 1034592
• Web: www.omnicomm.com
• Phone: 954-473-1254
• Fax: N/A
• Employees: 175
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $3.69 million
• Net Margins: -2.67%
• Pretax Margin: N/A
• Return on Equity: -13.18%
• Return on Assets: -6.95%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.51
• Quick Ratio: 0.51

Sales & Book Value

• Annual Sales: $27.10 million
• Price / Sales: 2.44
• Cash Flow: $0.03 per share
• Price / Cash Flow: 14.62
• Book Value: ($0.07) per share
• Price / Book: -5.86

Miscellaneous

• Outstanding Shares: 161,073,000
• Free Float: N/A
• Market Cap: $66.04 million
• Optionable: Not Optionable
• Beta: 0.67